论文信息 - Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial - 字舞流文

Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

S. Yusuf | J. Bosch | P. López-Jaramillo | M. Loeb | M. Farkouh | J. Eikelboom | R. Lopes | Sonia S Anand | E. Belley‐Cote | S. Bangdiwala | S. Rangarajan | A. Avezum | S. Jolly | M. Hassany | R. Whitlock | A. Yusufali | A. Almas | Sanjib Kumar Sharma | O. Berwanger | S. Choudhri | C. Félix | Lizhen Xu | S. Wasserman | W. Harper | M. Luz Diaz | W. Tarhuni | R. Diaz | O. Drapkina | Laura Heenan | L. Heenan | Aysha Almas | Á. Avezum | R. Díaz